Table of Contents Author Guidelines Submit a Manuscript
Sarcoma
Volume 2012, Article ID 578052, 9 pages
http://dx.doi.org/10.1155/2012/578052
Review Article

Extra-Abdominal Desmoid Tumours: A Review of the Literature

Department of Orthopaedics, St. Vincent's University Hospital, Elm Park, Dublin 4, Ireland

Received 10 May 2012; Revised 2 July 2012; Accepted 8 July 2012

Academic Editor: R. Pollock

Copyright © 2012 A. P. Molloy et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. H. S. Hosalkar, J. T. Torbert, E. J. Fox, T. F. Delaney, A. J. Aboulafia, and R. D. Lackman, “Musculoskeletal desmoid tumors,” Journal of the American Academy of Orthopaedic Surgeons, vol. 16, no. 4, pp. 188–198, 2008. View at Google Scholar · View at Scopus
  2. E. E. Pakos, P. G. Tsekeris, and A. C. Goussia, “Desmoid tumours of the extremities and trunk: a review of the literature,” International Orthopaedics, vol. 29, no. 4, pp. 210–213, 2005. View at Publisher · View at Google Scholar · View at Scopus
  3. P. J. Papagelopoulos, A. F. Mavrogenis, E. A. Mitsiokapa, K. T. Papaparaskeva, E. C. Galanis, and P. N. Soucacos, “Current trends in the management of extra-abdominal desmoid tumours,” World Journal of Surgical Oncology, vol. 4, article 21, 2006. View at Publisher · View at Google Scholar · View at Scopus
  4. A. Duggal, I. C. Dickinson, S. Sommerville, and P. Gallie, “The management of extra-abdominal desmoid tumours,” International Orthopaedics, vol. 28, no. 4, pp. 252–256, 2004. View at Publisher · View at Google Scholar · View at Scopus
  5. C. Meazza, G. Bisogno, A. Gronchi et al., “Aggressive fibromatosis in children and adolescents: the italian experience,” Cancer, vol. 116, no. 1, pp. 233–240, 2010. View at Publisher · View at Google Scholar · View at Scopus
  6. H. J. Mankin, F. J. Hornicek, and D. S. Springfield, “Extra-abdominal desmoid tumors: a report of 234 cases,” Journal of Surgical Oncology, vol. 102, no. 5, pp. 380–384, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. E. B. G. García and N. V. Knoers, “Gardner's syndrome (familial adenomatous polyposis): a cilia-related disorder,” The Lancet Oncology, vol. 10, no. 7, pp. 727–735, 2009. View at Publisher · View at Google Scholar · View at Scopus
  8. M. Giarola, D. Wells, P. Mondini et al., “Mutations of adenomatous polyposis coli (APC) gene are uncommon in sporadic desmoid tumours,” British Journal of Cancer, vol. 78, no. 5, pp. 582–587, 1998. View at Google Scholar · View at Scopus
  9. T. Fallen, M. Wilson, B. Morlan, and N. M. Lindor, “Desmoid tumors—a characterization of patients seen at Mayo Clinic 1976–1999,” Familial Cancer, vol. 5, no. 2, pp. 191–194, 2006. View at Publisher · View at Google Scholar · View at Scopus
  10. M. H. Nieuwenhuis, M. Casparie, L. M. H. Mathus-Vliegen, O. M. Dekkers, P. C. W. Hogendoorn, and H. F. A. Vasen, “A nation-wide study comparing sporadic and familial adenomatous polyposis-related desmoid-type fibromatoses,” International Journal of Cancer, vol. 129, no. 1, pp. 256–261, 2011. View at Publisher · View at Google Scholar · View at Scopus
  11. B. P. M. Dalén, P. M. Bergh, and B. U. P. Gunterberg, “Desmoid tumors: a clinical review of 30 patients with more than 20 years' follow-up,” Acta Orthopaedica Scandinavica, vol. 74, no. 4, pp. 455–459, 2003. View at Publisher · View at Google Scholar · View at Scopus
  12. H. Ozger, L. Eralp, B. Toker, F. Aǧaoǧlu, and Y. Dizdar, “Evaluation of prognostic factors affecting recurrences and disease-free survival in extra-abdominal desmoid tumors,” Acta Orthopaedica et Traumatologica Turcica, vol. 41, no. 4, pp. 291–294, 2007. View at Google Scholar · View at Scopus
  13. A. Gronchi, P. G. Casali, L. Mariani et al., “Quality of surgery and outcome in extra-abdominal aggressive fibromatosis: a series of patients surgically treated at a single institution,” Journal of Clinical Oncology, vol. 21, no. 7, pp. 1390–1397, 2003. View at Publisher · View at Google Scholar · View at Scopus
  14. C. Chew, R. Reid, and P. J. O'Dwyer, “Evaluation of the long term outcome of patients with extremity desmoids,” European Journal of Surgical Oncology, vol. 30, no. 4, pp. 428–432, 2004. View at Publisher · View at Google Scholar · View at Scopus
  15. M. F. C. Amary, P. Pauwels, E. Meulemans et al., “Detection of β-catenin mutations in paraffin-embedded sporadic desmoid-type fibromatosis by Mutation-specific Restriction Enzyme Digestion (MSRED): an ancillary diagnostic tool,” American Journal of Surgical Pathology, vol. 31, no. 9, pp. 1299–1309, 2007. View at Publisher · View at Google Scholar · View at Scopus
  16. N. H. Jenkins, L. S. Freedman, and B. McKibbin, “Spontaneous regression of a desmoid tumour,” Journal of Bone and Joint Surgery, vol. 68, no. 5, pp. 780–781, 1986. View at Google Scholar · View at Scopus
  17. J. E. Strode, “Desmoid tumors particularly as related to their surgical removal,” Annals of Surgery, vol. 139, no. 3, pp. 335–334, 1954. View at Publisher · View at Google Scholar
  18. I. Dahn, N. Jonsson, and G. Lundh, “Desmoid tumours. A series of 33 cases,” Acta Chirurgica Scandinavica, vol. 126, pp. 305–314, 1963. View at Google Scholar · View at Scopus
  19. D. J. Lips, N. Barker, H. Clevers, and A. Hennipman, “The role of APC and beta-catenin in the aetiology of aggressive fibromatosis (desmoid tumors),” European Journal of Surgical Oncology, vol. 35, no. 1, pp. 3–10, 2009. View at Publisher · View at Google Scholar · View at Scopus
  20. J. M. Trent, R. Wiltshire, L. K. Su, N. C. Nicolaides, B. Vogelstein, and K. W. Kinzler, “The gene for the APC-binding protein β-catenin (CTNNB1) maps to chromosome 3p22, a region frequently altered in human malignancies,” Cytogenetics and Cell Genetics, vol. 71, no. 4, pp. 343–344, 1995. View at Google Scholar · View at Scopus
  21. E. Dejana, F. Orsenigo, and M. G. Lampugnani, “The role of adherens junctions and VE-cadherin in the control of vascular permeability,” Journal of Cell Science, vol. 121, no. 13, pp. 2115–2122, 2008. View at Publisher · View at Google Scholar · View at Scopus
  22. T. Ishitani, J. Ninomiya-Tsuji, and K. Matsumoto, “Regulation of lymphoid enhancer factor 1/T-cell factor by mitogen-activated protein kinase-related Nemo-like kinase-dependent phosphorylation in Wnt/β-catenin signaling,” Molecular and Cellular Biology, vol. 23, no. 4, pp. 1379–1389, 2003. View at Publisher · View at Google Scholar · View at Scopus
  23. Y. Kong, R. Poon, P. Nadesan et al., “Matrix metalloproteinase activity modulates tumor size, cell motility, and cell invasiveness in murine aggressive fibromatosis,” Cancer Research, vol. 64, no. 16, pp. 5795–5803, 2004. View at Publisher · View at Google Scholar · View at Scopus
  24. C. Wu, S. Nik-Amini, P. Nadesan, W. L. Stanford, and B. A. Alman, “Aggressive fibromatosis (desmoid tumor) is derived from mesenchymal progenitor cells,” Cancer Research, vol. 70, no. 19, pp. 7690–7698, 2010. View at Publisher · View at Google Scholar · View at Scopus
  25. H. Matono, S. Tamiya, R. Yokoyama et al., “Abnormalities of the Wnt/β-catenin signalling pathway induce tumour progression in sporadic desmoid tumours: correlation between β-catenin widespread nuclear expression and VEGF overexpression,” Histopathology, vol. 59, no. 3, pp. 368–367, 2011. View at Google Scholar
  26. C. Colombo, S. Bolshakov, S. Hajibashi et al., “Difficult to diagnose' desmoid tumours: a potential role for CTNNB1 mutational analysis,” Histopathology, vol. 59, no. 2, pp. 336–340, 2011. View at Google Scholar
  27. S. Signoroni, M. Frattini, T. Negri et al., “Cyclooxygenase-2 and platelet-derived growth factor receptors as potential targets in treating aggressive fibromatosis,” Clinical Cancer Research, vol. 13, no. 17, pp. 5034–5040, 2007. View at Publisher · View at Google Scholar · View at Scopus
  28. L. Picariello, F. Tonelli, and M. L. Brandi, “Selective oestrogen receptor modulators in desmoid tumours,” Expert Opinion on Investigational Drugs, vol. 13, no. 11, pp. 1457–1468, 2004. View at Publisher · View at Google Scholar · View at Scopus
  29. A. Michopoulou, S. Germanos, D. Kanakopoulos et al., “Management of a large abdominal wall desmoid tumor during pregnancy. Case report,” Annali Italiani di Chirurgia, vol. 81, no. 2, pp. 153–156, 2010. View at Google Scholar · View at Scopus
  30. G. Guglielmi, A. Cifaratti, G. Scalzo, and N. Magarelli, “Imaging of superficial and deep fibromatosis,” Radiologia Medica, vol. 114, no. 8, pp. 1292–1307, 2009. View at Publisher · View at Google Scholar · View at Scopus
  31. Q. Y. Liu, J. Y. Chen, B. L. Liang, H. G. Li, M. Gao, and X. F. Lin, “Imaging manifestations and pathologic features of soft tissue desmoid-type fibromatosis,” Ai Zheng, vol. 27, no. 12, pp. 1287–1292, 2008. View at Google Scholar · View at Scopus
  32. F. O'Keefe, E. E. Kim, and S. Wallace, “Magnetic resonance imaging in aggressive fibromatosis,” Clinical Radiology, vol. 42, no. 3, pp. 170–173, 1990. View at Publisher · View at Google Scholar · View at Scopus
  33. C. A. Kingston, C. M. Owens, A. Jeanes, and M. Malone, “Imaging of desmoid fibromatosis in pediatric patients,” American Journal of Roentgenology, vol. 178, no. 1, pp. 191–199, 2002. View at Google Scholar · View at Scopus
  34. S. W. Weiss and J. R. Goldblum, “Fibromatoses,” in Eizinger and Weiss's Soft tissue tumours, pp. 309–346, 4th edition, 2001. View at Google Scholar
  35. J. R. Goellner and E. H. Soule, “Desmoid tumors. An ultrastructural study of eight cases,” Human Pathology, vol. 11, no. 1, pp. 43–50, 1980. View at Google Scholar · View at Scopus
  36. C. L. Owens, R. Sharma, and S. Z. Ali, “Deep fibromatosis (desmoid tumor): cytopathologic characteristics, clinicoradiologic features, and immunohistochemical findings on fine-needle aspiration,” Cancer, vol. 111, no. 3, pp. 166–172, 2007. View at Publisher · View at Google Scholar · View at Scopus
  37. M. Fiore, F. Rimareix, L. Mariani et al., “Desmoid-type fibromatosis: a front-line conservative approach to select patients for surgical treatment,” Annals of Surgical Oncology, vol. 16, no. 9, pp. 2587–2593, 2009. View at Publisher · View at Google Scholar · View at Scopus
  38. E. de Bree, R. Keus, J. Mellissas, D. Tsiftsis, and F. van Coevorden, “Desmoid tumors: need for an individualized approach,” Expert Review of Anticancer Therapy, vol. 9, no. 4, pp. 525–535, 2009. View at Publisher · View at Google Scholar · View at Scopus
  39. S. Salas, A. Dufresne, B. Bui et al., “Prognostic factors influencing progression-free survival determined from a series of sporadic desmoid tumors: a wait-and-see policy according to tumor presentation,” Journal of Clinical Oncology, vol. 29, no. 26, pp. 3553–3558, 2011. View at Publisher · View at Google Scholar
  40. W. P. Francis, D. Zippel, L. A. MacK et al., “Desmoids: a revelation in biology and treatment,” Annals of Surgical Oncology, vol. 16, no. 6, pp. 1650–1654, 2009. View at Publisher · View at Google Scholar · View at Scopus
  41. K. Huang, H. Fu, Y. Q. Shi, Y. Zhou, and C. Y. Du, “Prognostic factors for extra-abdominal and abdominal wall desmoids: a 20-year experience at a single institution,” Journal of Surgical Oncology, vol. 100, no. 7, pp. 563–569, 2009. View at Publisher · View at Google Scholar · View at Scopus
  42. M. G. Rock, D. J. Pritchard, and H. M. Reiman, “Extra-abdominal desmoid tumors,” Journal of Bone and Joint Surgery, vol. 66, no. 9, pp. 1369–1374, 1984. View at Google Scholar · View at Scopus
  43. J. J. Nuyttens, P. F. Rust, C. R. Thomas Jr., and A. T. Turrisi III, “Surgery versus radiation therapy for patients with aggressive fibromatosis or desmoid tumors: a comparative review of 22 articles,” Cancer, vol. 88, no. 7, pp. 1517–1523, 2000. View at Google Scholar
  44. J. J. Lewis, P. J. Boland, D. H. Y. Leung, J. M. Woodruff, and M. F. Brennan, “The enigma of desmoid tumors,” Annals of Surgery, vol. 229, no. 6, pp. 866–873, 1999. View at Publisher · View at Google Scholar · View at Scopus
  45. J. Fontanesi, M. P. Mott, M. J. Kraut, D. P. Lucas, and P. R. Miller, “The role of postoperative irradiation in the treatment of locally recurrent incompletely resected extra-abdominal desmoid tumors,” Sarcoma, vol. 8, no. 2-3, pp. 83–86, 2004. View at Publisher · View at Google Scholar · View at Scopus
  46. H. A. Rüdiger, S. Y. K. Ngan, M. Ng, G. J. Powell, and P. F. M. Choong, “Radiation therapy in the treatment of desmoid tumours reduces surgical indications,” European Journal of Surgical Oncology, vol. 36, no. 1, pp. 84–88, 2010. View at Publisher · View at Google Scholar · View at Scopus
  47. M. S. Rutenberg, D. J. Indelicato, J. A. Knapik et al., “External-beam radiotherapy for pediatric and young adult desmoid tumors,” Pediatric Blood and Cancer, vol. 57, no. 3, pp. 435–442, 2011. View at Publisher · View at Google Scholar · View at Scopus
  48. A. J. Weiss and R. D. Lackman, “Low-dose chemotherapy of desmoid tumors,” Cancer, vol. 64, no. 6, pp. 1192–1194, 1989. View at Google Scholar · View at Scopus
  49. T. Pilz, T. B. Pilgrim, G. Bisogno et al., “Chemotherapy in fibromatoses of childhood and adolescence: experiences of the German Cooperative Soft Tissue Sarcoma Study (CWS) and the Italian Cooperative Study Group (ICG-AIEOP),” Klinische Padiatrie, vol. 211, no. 4, pp. 291–295, 1999. View at Google Scholar · View at Scopus
  50. D. Garbay, A. Le Cesne, N. Penel et al., “Chemotherapy in patients with desmoid tumors: a study from the French Sarcoma Group (FSG),” Annals of Oncology, vol. 23, no. 1, pp. 182–186, 2012. View at Publisher · View at Google Scholar
  51. S. X. Skapek, W. S. Ferguson, L. Granowetter et al., “Vinblastine and methotrexate for desmoid fibromatosis in children: results of a Pediatric Oncology Group phase II trial,” Journal of Clinical Oncology, vol. 25, no. 5, pp. 501–506, 2007. View at Publisher · View at Google Scholar · View at Scopus
  52. S. R. Patel and R. S. Benjamin, “Desmoid tumors respond to chemotherapy: defying the dogma in oncology,” Journal of Clinical Oncology, vol. 24, no. 1, pp. 11–12, 2006. View at Publisher · View at Google Scholar · View at Scopus
  53. M. Gega, H. Yanagi, R. Yoshikawa et al., “Successful chemotherapeutic modality of doxorubicin plus dacarbazine for the treatment of desmoid tumors in association with familial adenomatous polyposis,” Journal of Clinical Oncology, vol. 24, no. 1, pp. 102–105, 2006. View at Publisher · View at Google Scholar · View at Scopus
  54. A. Constantinidou, R. L. Jones, M. Scurr, O. Al-Muderis, and I. Judson, “Advanced aggressive fibromatosis: effective palliation with chemotherapy,” Acta Oncologica, vol. 50, no. 3, pp. 455–461, 2011. View at Publisher · View at Google Scholar · View at Scopus
  55. R. Poon, R. Smits, C. Li et al., “Cyclooxygenase-two (COX-2) modulates proliferation in aggressive fibromatosis (desmoid tumor),” Oncogene, vol. 20, no. 4, pp. 451–460, 2001. View at Publisher · View at Google Scholar · View at Scopus
  56. Y. Nishida, S. Tsukushi, Y. Shido, J. Wasa, N. Ishiguro, and Y. Yamada, “Successful treatment with meloxicam, a cyclooxygenase-2 inhibitor, of patients with extra-abdominal desmoid tumors: a pilot study,” Journal of Clinical Oncology, vol. 28, no. 6, pp. e107–e109, 2010. View at Publisher · View at Google Scholar · View at Scopus
  57. N. L. Cho, A. M. Carothers, H. Rizvi, R. M. Hasson, M. Redston, and M. M. Bertagnolli, “Immunohistochemical and molecular analysis of tyrosine kinase activity in desmoid tumors,” Journal of Surgical Research, vol. 173, no. 2, pp. 320–326, 2012. View at Publisher · View at Google Scholar · View at Scopus
  58. J. Mace, J. Sybil Biermann, V. Sondak et al., “Response of extraabdominal desmoid tumors to therapy with imatinib mesylate,” Cancer, vol. 95, no. 11, pp. 2373–2379, 2002. View at Publisher · View at Google Scholar · View at Scopus
  59. K. M. Skubitz, J. C. Manivel, D. R. Clohisy, and J. W. Frolich, “Response of imatinib-resistant extra-abdominal aggressive fibromatosis to sunitinib: case report and review of the literature on response to tyrosine kinase inhibitors,” Cancer Chemotherapy and Pharmacology, vol. 64, no. 3, pp. 635–640, 2009. View at Publisher · View at Google Scholar · View at Scopus
  60. M. C. Heinrich, G. A. McArthur, G. D. Demetri et al., “Clinical and molecular studies of the effect of imatinib on advanced aggressive fibromatosis (desmoid tumor),” Journal of Clinical Oncology, vol. 24, no. 7, pp. 1195–1203, 2006. View at Publisher · View at Google Scholar · View at Scopus
  61. N. Penel, A. Le Cesne, B. N. Bui et al., “Imatinib for progressive and recurrent aggressive fibromatosis (desmoid tumors): an FNCLCC/French Sarcoma Group phase II trial with a long-term follow-up,” Annals of Oncology, vol. 22, no. 2, pp. 452–457, 2011. View at Publisher · View at Google Scholar · View at Scopus
  62. R. Chugh, J. K. Wathen, S. R. Patel et al., “Efficacy of imatinib in aggressive fibromatosis: results of a phase II multicenter Sarcoma Alliance for Research through Collaboration (SARC) trial,” Clinical Cancer Research, vol. 16, no. 19, pp. 4884–4891, 2010. View at Publisher · View at Google Scholar · View at Scopus
  63. L. Liu, Y. Cao, C. Chen et al., “Sorafenib blocks the RAF/MEK/ERK pathway, inhibits tumor angiogenesis, and induces tumor cell apoptosis in hepatocellular carcinoma model PLC/PRF/5,” Cancer Research, vol. 66, no. 24, pp. 11851–11858, 2006. View at Publisher · View at Google Scholar · View at Scopus
  64. M. M. Gounder, R. A. Lefkowitz, M. L. Keohan et al., “Activity of sorafenib against desmoid tumor/deep fibromatosis,” Clinical Cancer Research, vol. 17, no. 12, pp. 4082–4090, 2011. View at Publisher · View at Google Scholar · View at Scopus
  65. J. L. Kujak, P. T. Liu, G. B. Johnson, and M. R. Callstrom, “Early experience with percutaneous cryoablation of extra-abdominal desmoid tumors,” Skeletal Radiology, vol. 39, no. 2, pp. 175–182, 2010. View at Publisher · View at Google Scholar · View at Scopus